Literature DB >> 27920025

Biology and Genetics of PrP Prion Strains.

Sina Ghaemmaghami1.   

Abstract

Prion diseases are a group of fatal neurodegenerative disorders caused by the misfolding of the cellular prion protein (PrPC) into a pathogenic conformation (PrPSc). PrPSc is capable of folding into multiple self-replicating prion strains that produce phenotypically distinct neurological disorders. Evidence suggests that the structural heterogeneity of PrPSc is the molecular basis of strain-specific prion properties. The self-templating of PrPSc typically ensures that prion strains breed true upon passage. However, prion strains also have the capacity to conformationally transform to maximize their rate of replication in a given environment. Here, we provide an overview of the prion-strain phenomenon and describe the role of strain adaptation in drug resistance. We also describe recent evidence that shows the presence of distinct conformational strains in other neurodegenerative disorders.
Copyright © 2017 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27920025      PMCID: PMC5538409          DOI: 10.1101/cshperspect.a026922

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  96 in total

1.  Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation.

Authors:  K Doh-Ura; T Iwaki; B Caughey
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

Review 2.  Shattuck lecture--neurodegenerative diseases and prions.

Authors:  S B Prusiner
Journal:  N Engl J Med       Date:  2001-05-17       Impact factor: 91.245

3.  Strain-specified relative conformational stability of the scrapie prion protein.

Authors:  D Peretz; M R Scott; D Groth; R A Williamson; D R Burton; F E Cohen; S B Prusiner
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

4.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

5.  Adaptation and selection of prion protein strain conformations following interspecies transmission of transmissible mink encephalopathy.

Authors:  J C Bartz; R A Bessen; D McKenzie; R F Marsh; J M Aiken
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

6.  Potent inhibition of scrapie prion replication in cultured cells by bis-acridines.

Authors:  Barnaby C H May; Aaron T Fafarman; Septima B Hong; Michael Rogers; Leslie W Deady; Stanley B Prusiner; Fred E Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-07       Impact factor: 11.205

7.  Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease.

Authors:  C Korth; B C May; F E Cohen; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

8.  Effectiveness of polyene antibiotics in treatment of transmissible spongiform encephalopathy in transgenic mice expressing Syrian hamster PrP only in neurons.

Authors:  R Demaimay; R Race; B Chesebro
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

9.  Evaluation of quinacrine treatment for prion diseases.

Authors:  A Barret; F Tagliavini; G Forloni; C Bate; M Salmona; L Colombo; A De Luigi; L Limido; S Suardi; G Rossi; F Auvré; K T Adjou; N Salès; A Williams; C Lasmézas; J P Deslys
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

10.  Quinacrine does not prolong survival in a murine Creutzfeldt-Jakob disease model.

Authors:  Steven J Collins; Victoria Lewis; Marcus Brazier; Andrew F Hill; Ashley Fletcher; Colin L Masters
Journal:  Ann Neurol       Date:  2002-10       Impact factor: 10.422

View more
  5 in total

1.  Aβ Plaques.

Authors:  Lary C Walker
Journal:  Free Neuropathol       Date:  2020-10-30

Review 2.  Structural Bases of Prion Variation in Yeast.

Authors:  Vitaly V Kushnirov; Alexander A Dergalev; Maya K Alieva; Alexander I Alexandrov
Journal:  Int J Mol Sci       Date:  2022-05-20       Impact factor: 6.208

3.  Mammalian amyloidogenic proteins promote prion nucleation in yeast.

Authors:  Pavithra Chandramowlishwaran; Meng Sun; Kristin L Casey; Andrey V Romanyuk; Anastasiya V Grizel; Julia V Sopova; Aleksandr A Rubel; Carmen Nussbaum-Krammer; Ina M Vorberg; Yury O Chernoff
Journal:  J Biol Chem       Date:  2018-01-12       Impact factor: 5.157

4.  A dominant-negative mutant inhibits multiple prion variants through a common mechanism.

Authors:  Fen Pei; Susanne DiSalvo; Suzanne S Sindi; Tricia R Serio
Journal:  PLoS Genet       Date:  2017-10-30       Impact factor: 5.917

5.  Spin Label Scanning Reveals Likely Locations of β-Strands in the Amyloid Fibrils of the Ure2 Prion Domain.

Authors:  Jingzhou Wang; Giovanna Park; Yoon Kyung Lee; Matthew Nguyen; Tiffany San Fung; Tiffany Yuwen Lin; Frederick Hsu; Zhefeng Guo
Journal:  ACS Omega       Date:  2020-03-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.